Phase I study of vaccine therapy with a cocktail of peptides for pediatric patients with refractory solid tumors

被引：1
|
作者：
Akazawa, Yu
Hosono, Ako
Yoshikawa, Toshiaki
Kaneda, Hide
Hara, Junichi
Kinoshita, Yoshiaki
Kohashi, Kenichi
Manabe, Atsushi
Shioda, Yoko
Shoda, Kayoko
Shimomura, Manami
Mizuno, Shoichi
Nakamoto, Yasunari
Nakatsura, Tetsuya
机构：
[1] Natl Canc Ctr, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Osaka City Gen Hosp, Osaka, Japan
[4] Kyushu Univ Hosp, Fukuoka, Japan
[5] St Lukes Int Hosp, Tokyo, Japan
[6] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[7] Univ Fukui, Fukui, Japan
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A001
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
    Hosono, A.
    Yoshikawa, T.
    Tsuchiya, N.
    Fujinami, N.
    Saito, K.
    Mizuno, S.
    Nakatsura, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
    Hosono, Ako
    Yoshikawa, Toshiaki
    Fujinami, Norihiro
    Saito, Keigo
    Mizuno, Shoichi
    Tsuchiya, Nobuhiro
    Kinoshita, Yoshiaki
    Kohashi, Kenichi
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2018, 109 : 106 - 106
  • [3] Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
    Tsuchiya, Nobuhiro
    Hosono, Ako
    Yoshikawa, Toshiaki
    Shoda, Kayoko
    Nosaka, Kazuto
    Shimomura, Manami
    Hara, Junichi
    Nitani, Chika
    Manabe, Atsushi
    Yoshihara, Hiroki
    Hosoya, Yosuke
    Kaneda, Hide
    Kinoshita, Yoshiaki
    Kohashi, Kenichi
    Yoshimura, Kenichi
    Fujinami, Norihiro
    Saito, Keigo
    Mizuno, Shoichi
    Nakatsura, Tetsuya
    ONCOIMMUNOLOGY, 2018, 7 (01):
  • [4] Efficacy of the NCCV Cocktail-1 vaccine for refractory pediatric solid tumors: A phase I clinical trial
    Akazawa, Yu
    Hosono, Ako
    Yoshikawa, Toshiaki
    Kaneda, Hide
    Nitani, Chika
    Hara, Junichi
    Kinoshita, Yoshiaki
    Kohashi, Kenichi
    Manabe, Atsushi
    Fukutani, Miki
    Wakabayashi, Masashi
    Sato, Akihiro
    Shoda, Kayoko
    Shimomura, Manami
    Mizuno, Shoichi
    Nakamoto, Yasunari
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2019, 110 (12) : 3650 - 3662
  • [5] Phase I study of everolimus in pediatric patients with refractory solid tumors
    Fouladi, Maryam
    Laningham, Fred
    Wu, Jianrong
    O'Shaughnessy, Melinda A.
    Molina, Kristen
    Broniscer, Alberto
    Spunt, Sheri L.
    Luckett, Inga
    Stewart, Clinton F.
    Houghton, Peter J.
    Gilbertson, Richard J.
    Furman, Wayne L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4806 - 4812
  • [6] A phase I study of oxaliplatin and etoposide in pediatric patients with refractory solid tumors
    McGregor, L. M.
    Spunt, S. L.
    Santana, V. M.
    Stewart, C. F.
    Ward, D. A.
    Wu, J.
    Watkins, A.
    Ivy, S. P.
    Furman, W. L.
    Fouladi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase I study of DMP 840 in pediatric patients with refractory solid tumors
    Thompson, J
    Pratt, CB
    Stewart, CF
    Avery, L
    Bowman, L
    Zamboni, WC
    Pappo, A
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 45 - 49
  • [8] Phase I study of DMP 840 in pediatric patients with refractory solid tumors
    Joyce Thompson
    Charles B. Pratt
    Clinton F. Stewart
    Loraine Avery
    Laura Bowman
    William C. Zamboni
    Alberto Pappo
    Investigational New Drugs, 1998, 16 : 45 - 49
  • [9] Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors
    Spunt, Sheri L.
    Grupp, Stephan A.
    Vik, Terry A.
    Santana, Victor M.
    Greenblatt, David J.
    Clancy, Jill
    Berkenblit, Anna
    Krygowski, Mizue
    Ananthakrishnan, Revathi
    Boni, Joseph P.
    Gilbertson, Richard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) : 2933 - 2940
  • [10] A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors
    Paul J. Wood
    Robyn Strong
    Grant A. McArthur
    Michael Michael
    Elizabeth Algar
    Andrea Muscat
    Lin Rigby
    Melissa Ferguson
    David M. Ashley
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 493 - 503
12345